Synergistic effect of Ru(II)-based type II photodynamic therapy with cefotaxime on clinical isolates of ESBL-producing Klebsiella pneumoniae

Synergistic effect of Ru(II)-based type II photodynamic therapy with cefotaxime on clinical isolates of ESBL-producing Klebsiella pneumoniae

Multidrug-resistant bacteria, such as ESBL producing-Klebsiella pneumoniae, have increased substantially, encouraging the development of complementary therapies such as photodynamic inactivation (PDI). PDI uses photosensitizer (PS) compounds that kill bacteria using light to produce reactive oxygen...

Full description

Bibliographic Details
Main Authors: Dafne Berenice Hormazábal, Ángeles Beatriz Reyes, Francisco Castro, Alan R. Cabrera, Paulina Dreyse, Felipe Melo-González, Susan M. Bueno, Iván A. González, Christian Erick Palavecino
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Biomedicine & Pharmacotherapy
Subjects:
MDR bacteria
Mode of action
Complementary therapies, 6 log10 inhibition
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223007394

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223007394

Similar Items